APA (7th ed.) Citation

A, V., H, A., G, I., S, F., A, Z., N, F., . . . Á, V. (2025). Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy. European journal of neurology, 32(8), e70305. https://doi.org/10.1111/ene.70305

Chicago Style (17th ed.) Citation

A, Vilaseca, et al. "Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy." European Journal of Neurology 32, no. 8 (2025): e70305. https://doi.org/10.1111/ene.70305.

MLA (9th ed.) Citation

A, Vilaseca, et al. "Severity-Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19-Targeted CAR T-Cell Therapy." European Journal of Neurology, vol. 32, no. 8, 2025, p. e70305, https://doi.org/10.1111/ene.70305.